An Indian drug giant, little-known outside the vaccine world, has agreed to make and distribute a billion doses of a yet-to-be approved coronavirus vaccine—a move aimed at providing pandemic protection to the world’s poorest. AstraZeneca PLC this week tapped Serum Institute of India, or SII, to be part of a global manufacturing and distribution network for a potential coronavirus vaccine being developed by University of Oxford researchers. Under the agreement, SII would be the main contract manufacturer for low- and middle-income...

Source: Wall Street Journal June 06, 2020 20:48 UTC